Search research articles
Contact Us
Filters
Showing results (11-20 of 149) with videos related to
Page
of 15
Sort By:
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
August 28, 1999
Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure
D P Brooks, R R Ruffolo
European Journal of Pharmacology
|
December 29, 1995
Prevention of cyclosporine A-induced renal vasoconstriction by the endothelin receptor antagonist SB 209670
D P Brooks, L C Contino
The American Journal of Physiology
|
February 1, 1996
kappa-Opioid agonist inhibition of osmotically induced AVP release: preferential action at hypothalamic sites
N F Rossi, D P Brooks
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1992
The role of adenosine in glycine-induced glomerular hyperfiltration in rats
Y X Wang, D P Brooks
Nephron
|
January 1, 1996
Blockade of radiocontrast-induced nephrotoxicity by the endothelin receptor antagonist, SB 209670
D P Brooks, P D DePalma
The American Journal of Physiology
|
June 1, 1992
Dopamine DA1 receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats
Y X Wang, M Gellai, D P Brooks
The American Journal of Physiology
|
December 1, 1985
Hemorrhage in DOC-salt hypertensive rats: plasma and platelet vasopressin
J T Crofton, L Share, D P Brooks
Neuroendocrinology
|
January 1, 1986
Central adrenergic control of vasopressin release
D P Brooks, L Share, J T Crofton
Journal of Hypertension
|
June 1, 1986
Osmotic stimulation in DOC-salt hypertension: vasopressin and blood pressure
J T Crofton, L Share, D P Brooks
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1989
Gonadectomy abolishes the sexual dimorphism in DOC-salt hypertension in the rat
J T Crofton, L Share, D P Brooks
Page
of 15
Search research articles
Search
Showing results (11-20 of 149) with videos related to
Sort By:
Page
of 15
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
August 28, 1999
Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure
D P Brooks, R R Ruffolo
European Journal of Pharmacology
|
December 29, 1995
Prevention of cyclosporine A-induced renal vasoconstriction by the endothelin receptor antagonist SB 209670
D P Brooks, L C Contino
The American Journal of Physiology
|
February 1, 1996
kappa-Opioid agonist inhibition of osmotically induced AVP release: preferential action at hypothalamic sites
N F Rossi, D P Brooks
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1992
The role of adenosine in glycine-induced glomerular hyperfiltration in rats
Y X Wang, D P Brooks
Nephron
|
January 1, 1996
Blockade of radiocontrast-induced nephrotoxicity by the endothelin receptor antagonist, SB 209670
D P Brooks, P D DePalma
The American Journal of Physiology
|
June 1, 1992
Dopamine DA1 receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats
Y X Wang, M Gellai, D P Brooks
The American Journal of Physiology
|
December 1, 1985
Hemorrhage in DOC-salt hypertensive rats: plasma and platelet vasopressin
J T Crofton, L Share, D P Brooks
Neuroendocrinology
|
January 1, 1986
Central adrenergic control of vasopressin release
D P Brooks, L Share, J T Crofton
Journal of Hypertension
|
June 1, 1986
Osmotic stimulation in DOC-salt hypertension: vasopressin and blood pressure
J T Crofton, L Share, D P Brooks
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1989
Gonadectomy abolishes the sexual dimorphism in DOC-salt hypertension in the rat
J T Crofton, L Share, D P Brooks
Page
of 15